180 Life Sciences Corp. reported several warrant exercises for cash, resulting in the issuance or pending issuance of shares. On August 8, 2025, a holder exercised warrants for 25,000 shares at $2.28 each. On August 11, 2025, holders exercised warrants for 1,596 shares at $2.65 each and another for 185,000 shares at $2.28 each. On August 12, 2025, a holder exercised warrants for 1,335,862 shares at $1.50 each, and holders exercised warrants for 864,250 shares at $2.28 each, as well as 2,927 shares at $2.65 each. Lastly, on August 13, 2025, a holder exercised warrants for 25,000 shares at $2.28 each. These transactions did not involve public offerings and were conducted with accredited investors.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 180 Life Sciences Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-075707), on August 13, 2025, and is solely responsible for the information contained therein.